Registration number:
Ondine Biomedical Limited
for the Period from 18 January 2017 to 31 December 2017
Chartered Accountants
Belfry House
Champions Way
Hendon
London
NW4 1PX
Ondine Biomedical Limited
Contents
Company Information |
|
Accountants' Report |
|
Balance Sheet |
|
Notes to the Financial Statements |
Ondine Biomedical Limited
Company Information
Director |
Ms C M Cross |
Registered office |
|
Accountants |
|
Page 1 |
Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of
Ondine Biomedical Limited
for the Period Ended 31 December 2017
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Ondine Biomedical Limited for the period ended 31 December 2017 as set out on pages 3 to 5 from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/en/members/regulations-standards-and-guidance/.
This report is made solely to the director of Ondine Biomedical Limited in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Ondine Biomedical Limited and state those matters that we have agreed to state to the director of Ondine Biomedical Limited in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Ondine Biomedical Limited and its director as a body for our work or for this report.
It is your duty to ensure that Ondine Biomedical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Ondine Biomedical Limited. You consider that Ondine Biomedical Limited is exempt from the statutory audit requirement for the period.
We have not been instructed to carry out an audit or a review of the financial statements of Ondine Biomedical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
......................................
Chartered Accountants
Champions Way
Hendon
London
NW4 1PX
Page 2 |
Ondine Biomedical Limited
(Registration number: 10570442)
Balance Sheet as at 31 December 2017
Note |
2017 |
|
Current assets |
||
Cash at bank and in hand |
|
|
Creditors: Amounts falling due within one year |
( |
|
Net liabilities |
( |
|
Capital and reserves |
||
Called up share capital |
|
|
Retained earnings |
( |
|
Shareholder's funds |
( |
For the financial period ended 31 December 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
|
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. |
These financial statements have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. The statement of income and the director's report are not delivered to the Registrar of Companies.
Approved and authorised by the
.........................................
Ms C M Cross
Director
Page 3 |
Ondine Biomedical Limited
Notes to the Financial Statements for the Period from 18 January 2017 to 31 December 2017
General information |
The company is a private company limited by share capital incorporated in England. The registered office address is shown on page 1.
The principal place of business is:
888-1100 Melville Street
Vancouver
British Columbia
V6E 4A6
Canada
Accounting policies |
Statement of compliance
These financial statements which are the company's first financial statements, have been prepared in accordance with Financial Reporting Standard 102 Section 1A Small Entities and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention.
The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.
Summary of significant accounting policies
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Disclosure of long or short period
Going concern
The directors are of the opinion that the preparation of the financial statements on a going concern basis is justified on the grounds that assurance has been received from the shareholders that the company will continue to be supported for at least a year from the date of signing these financial statements.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand.
Employee information |
Apart from the directors the company had no other employees in the period. The directors did not receive any remuneration from the company in the period.
Page 4 |
Ondine Biomedical Limited
Notes to the Financial Statements for the Period from 18 January 2017 to 31 December 2017
Creditors |
2017 |
|
Due within one year |
|
Trade creditors |
|
Amounts owed to parent undertaking |
|
Accruals |
900 |
|
Related party transactions |
Loans from related parties
2017 |
Parent undertaking |
Advances during the period |
|
At end of period |
|
Terms of loan from parent undertaking
Parent undertaking and ultimate controlling party |
The company's immediate parent is
The ultimate parent is
The company is controlled by Ms C M Cross
Page 5 |